BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 25579107)

  • 1. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.
    Huh WK; Ault KA; Chelmow D; Davey DD; Goulart RA; Garcia FA; Kinney WK; Massad LS; Mayeaux EJ; Saslow D; Schiffman M; Wentzensen N; Lawson HW; Einstein MH
    Gynecol Oncol; 2015 Feb; 136(2):178-82. PubMed ID: 25579107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.
    Huh WK; Ault KA; Chelmow D; Davey DD; Goulart RA; Garcia FA; Kinney WK; Massad LS; Mayeaux EJ; Saslow D; Schiffman M; Wentzensen N; Lawson HW; Einstein MH
    J Low Genit Tract Dis; 2015 Apr; 19(2):91-6. PubMed ID: 25574659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.
    Huh WK; Ault KA; Chelmow D; Davey DD; Goulart RA; Garcia FAR; Kinney WK; Massad LS; Mayeaux EJ; Saslow D; Schiffman M; Wentzensen N; Lawson HW; Einstein MH
    Obstet Gynecol; 2015 Feb; 125(2):330-337. PubMed ID: 25569009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing for human papillomavirus in cervical cancer screening: a review of indications and methodology.
    Nishino HT; Tambouret RH; Wilbur DC
    Cancer Cytopathol; 2011 Aug; 119(4):219-27. PubMed ID: 21717588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening.
    Wright TC; Schiffman M; Solomon D; Cox JT; Garcia F; Goldie S; Hatch K; Noller KL; Roach N; Runowicz C; Saslow D
    Obstet Gynecol; 2004 Feb; 103(2):304-9. PubMed ID: 14754700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
    Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
    Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cancer screening among women who attend sexually transmitted diseases (STD) clinics: background paper for 2010 STD Treatment Guidelines.
    Datta SD; Saraiya M
    Clin Infect Dis; 2011 Dec; 53 Suppl 3():S153-9. PubMed ID: 22080268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting.
    Kotaniemi-Talonen L; Nieminen P; Anttila A; Hakama M
    Br J Cancer; 2005 Oct; 93(8):862-7. PubMed ID: 16189520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on primary HPV screening for cervical cancer prevention.
    Rizzo AE; Feldman S
    Curr Probl Cancer; 2018 Sep; 42(5):507-520. PubMed ID: 30146348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary hrHPV DNA testing in cervical cancer screening: how to manage screen-positive women? A POBASCAM trial substudy.
    Dijkstra MG; van Niekerk D; Rijkaart DC; van Kemenade FJ; Heideman DA; Snijders PJ; Meijer CJ; Berkhof J
    Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):55-63. PubMed ID: 23733907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very low human Papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests.
    Zhao C; Elishaev E; Yuan KH; Yu J; Austin RM
    Cancer; 2007 Oct; 111(5):292-7. PubMed ID: 17879368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2013 statement on human papillomavirus [corrected] test utilization.
    Davis Davey D; Goulart R; Nayar R;
    Acta Cytol; 2014; 58(2):113-6. PubMed ID: 24525558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior high-risk human papillomavirus testing and Papanicolaou test results of 70 invasive cervical carcinomas diagnosed in 2012: results of a retrospective multicenter study.
    Zhao C; Li Z; Nayar R; Levi AW; Winkler BA; Moriarty AT; Barkan GA; Rao J; Miller F; Fan F; Zhou Z; Si Q; Fischer AH; Sturgis CD; Jing X; Marshall CB; Witt BL; Birdsong GG; Crothers BA
    Arch Pathol Lab Med; 2015 Feb; 139(2):184-8. PubMed ID: 24694342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rate.
    Bulkmans NW; Bulk S; Ottevanger MS; Rozendaal L; Hellenberg SM; van Kemenade FJ; Snijders PJ; Boeke AJ; Meijer CJ
    J Clin Pathol; 2006 Nov; 59(11):1218-20. PubMed ID: 16943223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AACC Guidance Document on Cervical Cancer Detection: Screening, Surveillance, and Diagnosis.
    Zhu Y; Feldman S; Leung SOA; Creer MH; Warrick J; Williams N; Mastorides S
    J Appl Lab Med; 2023 Mar; 8(2):382-406. PubMed ID: 36881764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-risk human papillomavirus testing as a primary screening for cervical cancer: position statement by the Korean Society of Obstetrics and Gynecology and the Korean Society of Gynecologic Oncology.
    Kong TW; Kim M; Kim YH; Kim YB; Kim J; Kim JW; Park MH; Park JH; Rhee JH; Lim MC; Hong JS
    J Gynecol Oncol; 2020 Jan; 31(1):e31. PubMed ID: 31789003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer screening in the early post vaccine era.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
    Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary human papillomavirus testing in organized cervical screening.
    Dillner J
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):11-6. PubMed ID: 23299089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.